Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Revenue by Product

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Neuromuscular System Drugs	145.38M
Neuromuscular System Drugs Growth	6.68%
Anti-inflammatory, Analgesic and Anti-allergic Drugs	80.50M
Anti-inflammatory, Analgesic and Anti-allergic Drugs Growth	11.19%
Other Preparations	78.96M
Other Preparations Growth	-2.28%
Cardiovascular System Drug	70.09M
Cardiovascular System Drug Growth	0.86%
Gastrointestinal, Hepatobiliary System Drugs	61.52M
Gastrointestinal, Hepatobiliary System Drugs Growth	-12.74%
Respiratory System Drugs	53.83M
Respiratory System Drugs Growth	7.83%
Endocrine System Drugs	39.56M
Endocrine System Drugs Growth	-5.72%
Vitamins and Minerals	31.14M
Vitamins and Minerals Growth	2.88%
Urinary System Drugs	27.92M
Urinary System Drugs Growth	-19.17%
Other	22.52M
Other Growth	9.56%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Taiwan	610.54M
Taiwan Growth	0.84%
Asia	879.00K
Asia Growth	-30.68%